2005年（平成17年）
Matsuzaki Y, Hashimoto S, Fujita T, Suzuki T, Sakurai T, Matsushima K, Kawakami Y. Systematic identification of human melanoma antigens using serial analysis of gene expression (SAGE).J Immunother.28(1):10-19.2005 Jan-Feb
Sumimoto H, Yamagata S, Shimizu A, Miyoshi H, Mizuguchi H, Hayakawa T, Miyagishi M, Taira K and Kawakami Y.Gene therapy for human small cell lung carcinoma by inactivation of Skp-2 with virally mediated RNA interference. Gene Therapy.12(1):95-100.2005 Jan
Inozume T, Matsuzaki Y, Kurihara S, Fujita T, Yamamoto A, Aburatani H, Shimada S and Kawakami Y . Novel melanoma antigen, FCRL/FREB, identified by cDNA profile comparison using DNA chip are immunogenic in multiple melanoma patients. Int J Cancer.114(2):283-290.2005 Mar
Namiki T, Yanagawa S, Izumo T, Ishikawa M, Tachiban M, Kawakami Y , Yokozeki H, Nishioka K, KanekoY. Genomic alterations in primary cutaneous melanomas detected by metaphase comparative genomic hybridization with laser capture or manual microdissection: 6p gains may predict poor outcome. Cancer Genet Cytogenet.157(1):1-11.2005 Feb
Satoh T, Kimura K, Okano Y, Hirakata M, Kawakami Y, and Kuwana M. Lack of circulating autoantibodies to bone morphogenetic protein receptor-II or activin receptor-like kinase 1 in mixed connective tissue disease patients with pulmonary arterial hypertension. Rheumatology (Oxford).44(2):192-196.2005 Feb
Kuwana M, Matsuura E, Kobayashi Kazuko, Okazaki Y, Kaburaki J, Ikeda Y and Kawakami Y. Binding of β2-glycoprotein I to anionic phospholipids facilitates processing and presentation of a cryptic epitope that activates pathogenic autoreactive T cells. Blood.105(4):1552-1557.2005 Feb
Kawakami Y, Sumimoto H, Fujita T, Matsuzaki Y. Immunological detection of altered signaling molecules involved in melanoma development. Cancer Metastasis and Rev.24(2):357-366.2005 Jun
Iwata T , Fujita T, Hirao N, Matsuzaki Y, Okada T, Mochimaru H, Susumu N, Matsumoto E, Sugano K, Yamashita N, Nozawa S, and Kawakami Y. Frequent immune responses to a cancer/testis antigen,CAGE,in patients with microsatellite instability positive endometrial cancer. Clinical Cancer Res.11(10):3949-3957.2005 May
Okada T，Noji S, Goto Y, Iwata T, Fujita T, Okada T, Matsuzaki Y, Kuwana M, Hirakata M, Horii A, Matsuno S, Sunamura M and Kawakami Y. Immune responses to DNA mismatch repair enzymes hMSH2 and hPMS1 in patients with pancreatic cancer, dermatomyositis and polymyositis. Int J Cancer.116(6):925-933.2005 Oct
Yoshiura K, Nakaoka T, Nishishita T, Sato K, Yamamoto A, Shimada S, Saida T, Kawakami Y, Takahashi T, Fukuda H, Imajoh-Ohmi S, Oyaizu N, Yamashita N. Carbonic anhydrase-II is a tumor vessel endothelium-associated antigen targeted by dendritic cell therapy. Clin Cancer Res.11(22):8201-8207.2005 Nov
Ogawa Y, Kodama H, Kameyama K, Yamazaki K, Yasuoka H, Okamoto S, Inoko H, Kawakami Y, Kuwana M. Donor fibroblast chimerism in the pathogenic fibrotic lesion of human chronic graft-versus-host disease. Invest Ophthalmol Vis Sci.46(12):4519-4527.2005 Dec
Sumimoto Hidetoshi. Use of RNA interference technology for cancer specific gene silencing. Ann Cancer Res Therap.13(1&2):23-25.2005 Dec
Suzuki S, Satoh T, Yasuoka H, Hamaguchi Y, Tanaka K, Kawakami Y, Suzuki N, Kuwana M. Nobel autoantibodies to a voltage-gated potassium channel Kv1.4 in a severe form of myasthenia gravis. J of Neuroimmunology.170(1-2):141-149.2005 Dec
Kodama H, Inoue T, Watanabe R, Yasuoka H, Kawakami Y, Ogawa S, Ikeda Y, Mikoshiba K, Kuwana M. Cardiomyogenic Potential of Mesenchymal Progenitors Derived from Human Circulation CD14+ Monocytes. Stem Cells and Development.14(6):676-686.2005 Dec
Ohnishi M, Sakurai T, Heike Y, Yamazaki R, Kanda Y, Takaue Y, Mizoguchi H, and Kawakami YEvaluation of cytomegalovirus-specific T-cell reconstitution in patients after various allogeneic haematopoietic stem cell transplantation using interferon-gamma-enzyme-linked immunospot and human leucocyte antigen tetramer assays with an immunodominant T-cell epitope. Br J Haematol.131(4):472-479.2005 Nov